Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FRSW3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,221
Award facts
- Contract value 100% obligated
- $101,220.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $101,220.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pre-filled pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside competitive award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, psoriatic arthritis, ankylosing spondylitis, and other inflammatory diseases, representing a specialized pharmaceutical supply critical to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. Through this flexible contract vehicle, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating its established capability as a primary pharmaceutical vendor within the Defense Logistics Agency's supply chain.
Quick answers
Who was awarded contract SPE2DB25FRSW3?
SPE2DB25FRSW3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FRSW3 worth?
The government has obligated $101,221 on SPE2DB25FRSW3.
Is contract SPE2DB25FRSW3 an order under another contract?
Yes. SPE2DB25FRSW3 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRSW3 competed?
The extent of competition for SPE2DB25FRSW3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award